Size |
<10 nm |
Renal clearance |
– |
Add a penetration enhancer (PPS, polyacrylate, chitosan, phytic acid, self-assembling lipid-like peptides, thiomers, and lectins) to macromolecules to open TJs |
|
10–10 nm |
Peyer’s patches |
<50 nm: clathrin and caveolae independent; 50–100 nm: caveolae dependent |
|
100–200 nm |
Removed by MPS |
120 nm: clathrin dependent |
|
200–300 nm |
Spleen |
Macropinocytosis |
|
Surface composition |
Hydrophobic |
Immune cells |
N/A |
Avoid phagocytic clearance, prolong drug circulation, and improve biocompatibility by (i) adding hydrophilic polymers (PEGylation); or (ii) having biomimetic surfaces (CD47, leukocytes) |
|
Charge |
Positive |
Highly positive: taken up by macrophages |
Clathrin and macropinocytosis |
Positively charged nanomaterials interact more strongly with negatively charged intestinal cell membrane |
|
Neutral |
Appropriate for long circulation residency |
N/A |
|
Negative |
Highly negative: taken up by macrophages; slightly negative: appropriate for long circulation residency |
Caveolae mediated |
|
Shape |
Spherical |
Macrophages |
N/A |
Elliptical particles that escape macrophages and, after exposure to stimuli, change to a spherical form for better internalization |
|
Asymmetrical |
N/A |
N/A |
|
Elasticity and solubility |
Soft
|
Avoid immune system
|
Macropinocytosis
|
Add fatty acids and/or substitute amino acids |
Hard |
N/A |
Clathrin-dependent mechanisms |